Alma B. Pedersen. Studies based on the Danish Hip Arthroplasty Registry. Faculty of Health Sciences University of Aarhus, Denmark, 2006.

Theis M Thillemann. Use of medications and risk of revision after primary total hip arthroplasty. Faculty of Health Sciences University of Aarhus, Denmark, 2009

1. Lucht U. The Danish Hip Arthroplasty Register. Acta Orthop Scand 2000; 71 (5): 433-439.

2. A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T Sørensen, and U. Lucht. Registration in the Danish Hip Arthroplasty Registry. Completeness of total hip arthroplasties and positive predictive value of registered diagnosis and postoperative complications. Acta Orthop Scand 2004; 75 (4): 434-441.

3. A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T. Sørensen, and U. Lucht. Total hip arthroplasty. Incidence of primary operations and revisions 1996-2002 and estimated future demands. Acta Orthopaedica 2005; 76(2): 182-189.

4. A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T. Sørensen, and U. Lucht. Regional variation in incidence of primary total hip arthroplasties and revisions in Denmark, 1996-2002. Acta Orthopaedica 2005; 76 (6): 815-822.

5. L. Nikolajsen, B. Brandsborg, U. Lucht, T. S. Jensen and H. Kehlet. Chronic pain following total hip arthroplasty: A nationwide questionnaire study. Acta Anaesthesiologica Scandinavica 2006; 50: 495-500.

6. S. P. Johnsen, H. T. Sørensen, U. Lucht, K. Søballe, S. Overgaard, and A. B. Pedersen. Patient-related predictors of implant failure after primary total hip replacement in the initial, short- and long-terms. A nationwide danish follow-up study including 36 984 patients. J Bone Joint Surg Br 2006; 88-B:1303-8.

7. A. Paulsen, A. B. Pedersen, S. P. Johnsen, A. Riis, U. Lucht, S. Overgaard. Effect of hydroxyapatite coating on risk for revision after primary total hip arthroplasty in younger patients. Findings from the Danish Hip Arthroplasty Registry. Acta Orthop 2007 Oct;78(5):622-8.

8. Thillemann TM, Pedersen AB, Johnsen SP, Søballe K. Inferior outcome after intraoperative femoral fracture in total hip arthroplasty: outcome in 519 patients from the Danish Hip Arthroplasty Registry. Acta Orthop 2008 Jun; 79(3):327-34. 

9. Thillemann TM, Pedersen AB, Johnsen SP, Søballe K. Implant survival after primary total hip arthroplasty due to childhood hip disorders: Results from the Danish Hip Arthroplasty Registry. Acta Orthop 2008 Dec; 79(6): 769-776.

10. Pedersen AB, Mehnert F, Overgaard S, Møller B, og Johnsen SP. Transfusionspraksis ved total hoftealloplastik på danske ortopædkirurgiske afdelinger. Ugeskrift for Læger 2009; 171(12).

11. Søren Overgaard, Henrik Husted, Anders Odgaard, Alma B Pedersen, Christian Pedersen & Søren Solgaard. Resultater fra Dansk Hoftealloplastik Register Dansk Selskab for Hofte- og Knæalloplastikkirurgi. Ugeskrift for Læger 2009;171(13):1080 .

12. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Søballe K. Use of diuretics and risk of implant failure after primary total hip arthroplasty: a nationwide population-based study.  Bone 2009; 45: 499-504.

13. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, and Søballe K. The risk of revision after primary total hip arthroplasty among statin users: a nationwide population-based nested case-control study. Journal Bone Joint Surgery (Am). 2010 May;92(5):1063-72. 

14. Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, and Søballe K. Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone 2010 Apr;46(4):946-51. 

15. Pedersen AB, Mehnert F, Overgaard S, and Johnsen SP. Allogeneic blood transfusion and prognosis following total hip replacement: a population- based follow-up study. BMC Musculoskeletal Disorders 2009 Dec 29;10:167.

16. Sorensen CR, Pedersen AB, Johnsen SP, Riis A, and Overgaard S. Survival of Primary Total Hip Arthroplasty in Rheumatoid Arthritis patients. Findings in 1,661 arthroplasties in 1,395 patients from the Danish Hip Arthroplasty Registry. Acta Orthopaedica 2010. 81(1): 60-65.

17. Pedersen AB, Mehnert F, Sørensen HT, Overgaard S, and Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis: A Danish population-based follow-up study. Journal Bone Joint Surgery (Am) 2010. Accepted. 

18. Pedersen AB, Mehnert F, Johnsen SP and Sorensen HT. Diabetes Mellitus and survival of total hip arthroplasty in Denmark. Journal Bone Joint Surgery (Br) 2010. Accepted

19. Havelin LI, Fenstad AM, Salomonsson R, Mehnert F, Furnes O, Overgaard S, Pedersen AB, Herberts P, Kärrholm J, and Garellick G. The Nordic Arthroplasty Register association. A unique collaboration of three national hip arthroplasty registries with 280,201 total hip replacements. Acta Orthopaedica 2009; 80 (4): 393-401.

20. Pedersen AB, Svendsson J, Johnsen SP, Riis A, and Overgaard S. Risk factors for revision due to infection after primary total hip arthroplasty. Acta Orthopaedica 2009. Accepted.

21. Johansson PE, Fenstad AM,  Furnes O, Garellick G, Havelin L, Overgaard S, Pedersen AB, and Kärrholm J. Outcome following surface replacement hip arthroplasty in the Nordic Arthroplasty Register Association (NARA) database. Analysis of 1 638 cases from 1995 to 2007. Acta Orthopaedica 2009. Accepted.

1. A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T. Sørensen, and U. Lucht. Incidence of total hip arthroplasties and revisions in Denmark between 1996 and 2002 and estimated future demands. Abstract. 52nd congress of NOF, Reykjavik, June 16-19, 2004.

3. P. Kjærsgaard-Andersen, S. Paaske Johnsen, A. Riis, U. Lucht, S. Overgaard, and K. Jensen. Aseptic loosening of total hip arthroplasties after postoperative treatment with NSAIDs. DOS Årsmøde den 22. oktober 2004, Radisson SAS Scandinavia, Copenhagen: Arrangør: Dansk Ortopædisk Selskab (Awarded Best Paper at the Meeting).

4. A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T. Sørensen, and U. Lucht. Regional variation in incidence of primary total hip arthroplasties and revisions in Denmark 1996-2002. DOS Årsmøde den 22. oktober 2004, Radisson SAS Scandinavia, Copenhagen: Arrangør: Dansk Ortopædisk Selskab.

5. P. Kjærsgaard-Andersen, S. Paaske Johnsen, A. Riis, U. Lucht, S. Overgaard, and K. Jensen. Aseptic loosening of total hip arthroplasties after postoperative treatment with NSAIDs. Scientific Exhibition at the 72nd Annual Meeting of the AAOS. Washington, February 2005, USA.

6. P. Kjærsgaard-Andersen, S. Paaske Johnsen, A. Riis, U. Lucht, S. Overgaard, and K. Jensen. Aseptic loosening of total hip arthroplasties after postoperative treatment with NSAIDs. Scientific Exhibition at the 72nd Annual Meeting of the ORS. Washington, February 2005, USA.

7. A. Paulsen, S. Paaske Johnsen, A. Riis, A. Becic Pedersen, U. Lucht, and S. Overgaard. Survival of total hip arthroplasty in younger patients. Effect of hydroxyapatite coating and cement. DOS Årsmøde den 12-13. maj 2005, Aalborg: Arrangør: Dansk Ortopædisk Selskab.

8. A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T. Sørensen and U. Lucht. Patients characteristics and survival of total hip arthroplasties. DOS Årsmøde den 12-13. maj 2005, Aalborg. Arrangør: Dansk Ortopædisk Selskab.

9. A. B. Pedersen, A. Riis, U. Lucht, J. Jørgensen and S. P. Johnsen. Variation in use of blood transfusions among patients undergoing total hip arthroplasty at Danish hospitals. DOS Årsmøde den 27-28. oktober 2005, København. Arrangør: Dansk Ortopædisk Selskab.

10. A. Paulsen, S. Paaske Johnsen, A. Riis, A. Becic Pedersen, U. Lucht, and S. Overgaard. Survival of total hip arthroplasty in younger patients. Effect of hydroxyapatite coating and cement. Scientific Exhibition at the 73nd Annual Meeting of the ORS. Chicago, February 2006, USA.

11.  A. B. Pedersen, S. P. Johnsen, S. Overgaard, K. Søballe, H. T. Sørensen and U. Lucht. Patients characteristics and survival of total hip arthroplasties. Scientific Exhibition at the 73nd Annual Meeting of the AAOS. Chicago, February 2006, USA.

12. J, Svendsson, A. B. Pedersen, S. P. Johnsen, A. Riis, S. Overgaard. Risk factors for revision due to infection after primary total hip arthroplasty. 11 years follow up from the Danish Hip Arthroplasty Registry. DOS Årsmøde den 25.-26. oktober 2007, København. Arrangør: Dansk Ortopædisk Selskab.

13. C. Rud-Sørensen, A. B. Pedersen, S. P. Johnsen, A. Riis, S. Overgaard. Proteseoverlevelse efter primær total hoftealloplastik hos patienter opereret på grund af reumatoid artrit. DOS Årsmøde den 25.-26. oktober 2007, København. Arrangør: Dansk Ortopædisk Selskab.

16. T. M. Thillemann, A. B. Pedersen, S. P. Johnsen, K. Søballe. Increased risk of revision after sustaining intraoperative femoral fracture during total hip arthroplasty surgery. Results from the D4nish Hip Arthroplasty Registry. DOS Årsmøde den 25.-26. oktober 2007, København. Arrangør: Dansk Ortopædisk Selskab.

15. A.B. Pedersen, F. Mehnert, S. Overgaard, H.T. Sørensen, S.P. Johnsen. Patient related risk factors for venous thromboembolism following total hip replacement in Denmark: A nationwide population-based cohort study. DOS Årsmøde oktober 2008, København. Arrangør: Dansk Ortopædisk Selskab. DOS Bullettin. Nr. 6. Oktober 2008

16. T. M. Thillemann, A. B. Pedersen, S. P. Johnsen, K. Søballe. Decreased risk for revision after primary total hip arthroplasty among statin users: a nationwide populatoin-based nested case control study. DOS Årsmøde oktober 2008, København. Arrangør: Dansk Ortopædisk Selskab. DOS Bullettin. Nr. 6. Oktober 2008

17. A.B. Pedersen, F. Mehnert, S. Overgaard, S.P. Johnsen.Allogeneic blood transfusion and prognosis following total hip replacement. DOS Årsmøde oktober 2008, København. Arrangør: Dansk Ortopædisk Selskab. DOS Bullettin. Nr. 6. Oktober 2008

18. M. Krause, M.S. Kristensen, A.B. Pedersen, F. Mehnert, S. Overgaard. A comparision of patients and outcomes following total hip arthroplasty treated in public and private hospitals in Denmark. DOS Årsmøde oktober 2008, København. Arrangør: Dansk Ortopædisk Selskab. DOS Bullettin. Nr. 6. Oktober 2008